Summary

Asia Pacific Angioplasty Balloons Market is valued approximately at USD 600 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.52% over the forecast period 2024-2032. Angioplasty balloons are medical tools used in angioplasty procedures to treat blocked or narrowed blood vessels, particularly in the heart and other areas of the body. A catheter with an attached balloon is inserted into the affected artery and inflated at the blockage site, compressing the plaque or fatty deposits to widen the vessel and restore blood flow. This process helps alleviate conditions such as coronary artery disease and peripheral arterial disease, improving overall cardiovascular health. The growing focus on minimally invasive procedures and technological developments is a key trend for the Asia Pacific Angioplasty Balloons Market during the estimated period of 2024-2032. Minimally invasive procedures such as angioplasty are gaining traction among patients due to faster recovery times, reduced scarring, and lower complication risks compared to traditional open-heart surgery.

Factors such as the growing prevalence of cardiovascular diseases, advancements in healthcare infrastructure and a rising coronary and peripheral procedures are primarily attributing to the growth of the Asia Pacific Angioplasty Balloons Market. Asia Pacific market is witnessing a rise in the use of angioplasty balloons as a result of companies in the region making research & development investments to create novel balloons that improve safety, effectiveness, and patient outcomes. Additionally, exponential rise in the geriatric population is likely to fuel the demand of angioplasty balloons as they are prone to cardiovascular diseases, which are projected to bolster market growth. Moreover, positive government initiatives and policies aimed at improving healthcare access and promoting innovative medical technologies are also contributing to the growth of the angioplasty balloons market in the Asia Pacific region. However, high cost associated with the procedure, coupled with the complications associated with angioplasty procedures is expected to stifle Asia Pacific Angioplasty Balloons Market growth between 2022 and 2032.

The key countries considered for the Asia Pacific Angioplasty Balloons Market study includes China, India, Japan, South Korea, Australia and Rest of Asia Pacific. In 2023, China's Angioplasty Balloons Market holds a dominating position with the largest market share and is poised for further growth in the anticipated years. The market is experiencing rapid growth due to the growing awareness among both healthcare providers and patients in China about the benefits of minimally invasive procedures such as angioplasty. This awareness, coupled with a growing acceptance of innovative medical technologies, is boosting the market demand. Also, the rising incidence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease, as well as growing presence of both domestic and international companies in the Chinese angioplasty balloons market are further prompting the demand of the angioplasty balloons across the region. Whereas, the market in India is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:
Terumo Corporation
Microport Medical Shanghai Co. Ltd.
JW Medical Systems Ltd.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10


The detailed segments and sub-segment of the market are explained below:
By Product Type
Normal Balloons
Cutting/Scoring Balloons
Drug Eluting Balloons

By Application
Coronary Angioplasty
Peripheral Angioplasty

By End User
Hospitals
Ambulatory Surgical Centers
Other End Users
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Asia Pacific Angioplasty Balloons Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Asia Pacific Angioplasty Balloons Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product Type
2.3.2. By Application
2.3.3. By End User
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Angioplasty Balloons Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Angioplasty Balloons Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Angioplasty Balloons Market Size & Forecasts by Product Type 2022-2032
5.1. Normal Balloons
5.2. Cutting/Scoring Balloons
5.3. Drug Eluting Balloons
Chapter 6. Asia Pacific Angioplasty Balloons Market Size & Forecasts by Application 2022-2032
6.1. Coronary Angioplasty
6.2. Peripheral Angioplasty
Chapter 7. Asia Pacific Angioplasty Balloons Market Size & Forecasts by End User 2022-2032
7.1. Hospitals
7.2. Ambulatory Surgical Centers
7.3. Other End Users
Chapter 8. Asia Pacific Angioplasty Balloons Market Size & Forecasts by Country 2022-2032
8.1. China Angioplasty Balloons Market
8.1.1. Product Type breakdown size & forecasts, 2022-2032
8.1.2. Application breakdown size & forecasts, 2022-2032
8.1.3. End User breakdown size & forecasts, 2022-2032
8.2. India Angioplasty Balloons Market
8.3. Japan Angioplasty Balloons Market
8.4. Australia Angioplasty Balloons Market
8.5. South Korea Angioplasty Balloons Market
8.6. Rest of Asia Pacific Angioplasty Balloons Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Terumo Corporation
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Microport Medical Shanghai Co. Ltd.
9.3.3. JW Medical Systems Ltd.
9.3.4. Company 4
9.3.5. Company 5
9.3.6. Company 6
9.3.7. Company 7
9.3.8. Company 8
9.3.9. Company 9
9.3.10. Company 10
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes